Isolation of the Causative Microorganism and Antimicrobial Susceptibility of Impetigo / 대한피부과학회지
Korean Journal of Dermatology
;
: 788-794, 2012.
Artículo
en Coreano
| WPRIM
| ID: wpr-109153
ABSTRACT
BACKGROUND:
Impetigo is a common bacterial infection caused by Staphylococcus aureus, and group A beta-hemolytic Streptococcus or both. Recently, S. aureus has been reported as the most frequently isolated pathogen of impetigo and the incidence of methicillin-resistant S. aureus (MRSA) among patients with impetigo has increased.OBJECTIVE:
To investigate the predominant microorganism and the antibiotic susceptibility of the impetigo causative pathogen.METHODS:
Bacterial culture and antimicrobial susceptibility testing were performed in patients with impetigo from June 2006 to May 2012.RESULTS:
Of 164 patients, bacteria were cultured from 139 patients. Among them, S. aureus was isolated from 114 (82%) patients. The others were Acinetobacter baumannii, Enterobactercloacae, Enterococcus species, Enterococcus faecium, Enterococcus faecalis, Klebsiella oxytoca, and Candida albicans. The resistance rates of S. aureus against antibiotics were as follows penicillin, 95.6%; erythromycin, 43.9%; fusidicacid, 38.1%; clindamycin, 24.5%; gentamycin, 21%; tetracycline, 12.3%; trimethoprim-sulfamethoxazole, 0.9%; ciprofloxacin, 0%; habekacin, 0%; linezolid, 0%; teicoplanin, 0%; and vancomycin, 0%. Thirty-four (29.8%) S. aureus isolates were MRSA, and the prevalence of MRSA increased during the 6-year period.CONCLUSION:
The most predominant pathogen in impetigo was S. aureus, which was sensitive to ciprofloxacin, habekacin, linezolid, trimethoprim-sulfamethoxazole, teicoplanin, and vancomycin. An increase in the prevalence of MRSA was observed during the 6-year period, and the effective antibiotics for MRSA were trimethoprim-sulfamethoxazole, teicoplanin and vancomycin.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Penicilinas
/
Staphylococcus aureus
/
Streptococcus
/
Tetraciclina
/
Bacterias
/
Infecciones Bacterianas
/
Candida albicans
/
Clindamicina
/
Dibekacina
/
Gentamicinas
Tipo de estudio:
Estudio de incidencia
/
Estudio de prevalencia
/
Estudio pronóstico
Límite:
Humanos
Idioma:
Coreano
Revista:
Korean Journal of Dermatology
Año:
2012
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS